Cancer Proteome and Biomarkers

Cancer Proteome and Biomarkers

Proteomics technologies are employed in the discovery of novel therapeutic medicines and for early identification and diagnosis of malignancies. With advancements in the science of proteomics and the use of mass spectrometry, breast cancer observation, prognosis, diagnosis, and treatment are now possible.

With the development of proteomics technology, researchers have been able to distinguish between disease and disease-free states linked with breast cancer. Proteins expressed or discovered in serum, plasma, and tumour cells employing novel approaches provide for a better understanding of cancer heterogeneity. Proteomics in Breast Cancer Proteomics in Skin Cancer Proteomics in Lung Cancer Proteomics in Ovarian Cancer Proteomics in Colorectal Cancer.

 

  • Protein expression services and market analysis
  • Recombinant protein drugs

Related Conference of Cancer Proteome and Biomarkers

October 10-11, 2022

9th World Summit on Virology, Microbiology & Infectious Disease

Zurich, Switzerland
November 02-03, 2022

11th Global Medical Microbiology Summit & Expo   

Rome, Italy
November 17-18, 2022

International Virology Congress

Berlin, Germany
November 21-22, 2022

6th Global Summit on Microbiome

Budapest, Hungary
December 05-06, 2022

22nd Global Conference on Gerontology

Venice, Italy
December 06-07, 2022

4th International Conference on Bacteria and Microbiology

Berlin, Germany
December 07-08, 2022

World Congress on Microbiology and Microbes

Singapore City, Singapore
December 08-09, 2022

5th World Congress on Virology and Diseases Control

Tokyo, Japan
May 15-16, 2023

27th World Congress on Biotechnology

Prague, Czech Republic
July 26-27, 2023

29th Global Summit on Bioinformatics

Montreal, Canada

Cancer Proteome and Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in